|
Volumn 36, Issue 3, 2002, Pages 512-516
|
Risedronate for the prevention and treatment of corticosteroid-induced osteoporosis
|
Author keywords
Corticosteroid; Osteoporosis; Risedronate
|
Indexed keywords
BISPHOSPHONIC ACID DERIVATIVE;
CALCIUM;
CORTICOSTEROID;
PLACEBO;
PREDNISONE;
RISEDRONIC ACID;
VITAMIN D;
BONE DENSITY;
BONE MINERAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORTICOSTEROID THERAPY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
FEMUR NECK;
FRACTURE;
HUMAN;
LONG TERM CARE;
LUMBAR SPINE;
MALE;
MEDLINE;
MULTICENTER STUDY;
OSTEOPOROSIS;
PREMENOPAUSE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
|
EID: 0036195476
PISSN: 10600280
EISSN: None
Source Type: Journal
DOI: 10.1345/aph.1A114 Document Type: Review |
Times cited : (13)
|
References (30)
|